🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, positive reviews and detailed instructions for mixing or administering at home.

Within moments of joining one group, a vendor posted contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages display black plastic parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly serious health risks”.